Clinical Trials
VRC Clinical Trials |
VRC
Home |
CURRENT VRC CLINICAL
TRIALS
We are currently enrolling volunteers for a range of studies.
If you are interested in volunteering to participate in a
clinical trial, please call us at 1-866-833-LIFE (5433) or
e-mail us at VRCforlife@mail.nih.gov.
STUDIES
OPEN TO ACCRUAL
These studies are
recruiting.
VRC Clinical Trials
Related to Development of Vaccines for Prevention of HIV
VRC 000 (02-I-0127):
Screening
Subjects for HIV Vaccine Research Studies
VRC 012 (07-I-0167):
A
Phase I Clinical Trial of the Safety and Immunogenicity of
an HIV-1 Adenoviral Vector Serotype 35 Vaccine, VRC-HIVADV027-00-VP
(rAd35-EnvA): Dose Escalation as a Single Agent and Prime-Boost
Schedules with an HIV-1 Adenoviral Vector Serotype 5 Vaccine,
VRC-HIVADV038-00-VP (rAd5-EnvA), in Uninfected Adults
VRC 015 (08-I-0171):
A Phase I, Open-Label Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of a Multiclade Recombinant HIV-1 Adenoviral Vector Vaccine, VRC-HIVADV014-00-VP, in Uninfected Adults Randomized to Needle or Biojector Methods of Intramuscular Injection
VRC Clinical Trials
Related to Vaccines for Biodefense and Emerging Pathogens
VRC 300 (03-I-0285):
Screening
of Healthy Volunteers for Clinical Trials of Investigational
Vaccines to Prevent Infectious Diseases
VRC 205 (06-I-0237):
A
Phase I Clinical Trial to Evaluate the Safety and Immunogenicity
of a Recombinant Ebola Adenoviral Vector Vaccine, VRC-EBOADV018-00-VP,
in Healthy Adults
VRC 206 (08-I-0065)
A Phase I Study to Evaluate the Safety and Immunogenicity of an Ebola DNA Plasmid Vaccine, VRC-EBODNA023-00-VP, and a Marburg DNA Vaccine, VRC-MARDNA025-00-VP, in Healthy Adults
These studies are not
recruiting.
VRC Protocols to
Obtain Laboratory Samples for Vaccine and Immunology Research
VRC PAN (02-I-0066):
Studies
of Specific Immune Responses in Human Peripheral Blood Cells
in HIV-Infected and HIV-Uninfected Volunteers
VRC 200 (03-I-0263):
Apheresis
Procedures to Obtain Plasma or Peripheral Blood Mononuclear
Cells (PBMCs) for Research Studies
VRC Clinical Trials Related
to Development of Vaccines for Treatment of HIV
VRC 100 (03-I-0079):
Screening
HIV-Infected Subjects for Vaccine Research Studies
|
